{"id":"sotalol-or-amiodarone","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Bradycardia"},{"rate":"5-15","effect":"Hypotension"},{"rate":"5-10","effect":"Fatigue"},{"rate":"5-10","effect":"Dizziness"},{"rate":"variable","effect":"QT prolongation"},{"rate":"1-5","effect":"Torsades de pointes"},{"rate":"1-3","effect":"Pulmonary toxicity (Amiodarone)"},{"rate":"14-18","effect":"Thyroid dysfunction (Amiodarone)"},{"rate":"1-3","effect":"Hepatotoxicity"}]},"_chembl":{"chemblId":"CHEMBL1083993","moleculeType":"Small molecule","molecularWeight":"681.78"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sotalol is a Class III antiarrhythmic with beta-blocking properties that prolongs the action potential duration and refractory period. Amiodarone is a Class I, II, III, and IV antiarrhythmic with multiple mechanisms including sodium channel blockade, beta-blockade, potassium channel blockade, and calcium channel antagonism, making it effective against a broad spectrum of arrhythmias.","oneSentence":"Sotalol and Amiodarone are antiarrhythmic drugs that block potassium channels and slow electrical conduction in the heart to restore and maintain normal heart rhythm.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:37:55.756Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for rhythm control and stroke prevention"},{"name":"Ventricular arrhythmias including ventricular tachycardia"},{"name":"Supraventricular tachycardia"},{"name":"Maintenance of sinus rhythm after cardioversion"}]},"trialDetails":[{"nctId":"NCT06669299","phase":"NA","title":"Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies","status":"RECRUITING","sponsor":"IRCCS Ospedale San Raffaele","startDate":"2025-06-12","conditions":"Ventricular Tachycardia (VT)","enrollment":51},{"nctId":"NCT05034432","phase":"PHASE4","title":"The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2022-05-27","conditions":"Arrythmia, Cardiomyopathies","enrollment":100},{"nctId":"NCT05524077","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2020-07-08","conditions":"Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated","enrollment":162},{"nctId":"NCT07447297","phase":"NA","title":"Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2024-01-02","conditions":"Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter","enrollment":520},{"nctId":"NCT07405671","phase":"PHASE4","title":"Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2026-09","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease","enrollment":988},{"nctId":"NCT05790707","phase":"NA","title":"EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment","status":"RECRUITING","sponsor":"Poitiers University Hospital","startDate":"2023-04-21","conditions":"Mild Cognitive Impairment, Persistent Atrial Fibrillation","enrollment":120},{"nctId":"NCT06783868","phase":"","title":"Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control","status":"NOT_YET_RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2025-10","conditions":"Atrial Fibrillation, Stroke","enrollment":100},{"nctId":"NCT06322017","phase":"NA","title":"Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2024-04-09","conditions":"Atrial Fibrillation","enrollment":294},{"nctId":"NCT00540787","phase":"PHASE4","title":"A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Biosense Webster, Inc.","startDate":"2003-08-01","conditions":"Paroxysmal Atrial Fibrillation","enrollment":112},{"nctId":"NCT04037397","phase":"PHASE3","title":"First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-09-24","conditions":"Atrial Fibrillation","enrollment":25},{"nctId":"NCT02459574","phase":"NA","title":"Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-05-01","conditions":"Heart Failure, Recurrent Atrial Fibrillation","enrollment":321},{"nctId":"NCT02830360","phase":"PHASE4","title":"Antiarrhythmics or Ablation for Ventricular Tachycardia 2","status":"COMPLETED","sponsor":"John Sapp","startDate":"2016-10","conditions":"Ventricular Tachycardia (VT)","enrollment":416},{"nctId":"NCT04942834","phase":"NA","title":"Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2021-10-01","conditions":"Atrial Fibrillation, Persistent, Arrhythmias, Cardiac","enrollment":286},{"nctId":"NCT02389218","phase":"PHASE4","title":"A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent AF","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2015-03-03","conditions":"Atrial Fibrillation","enrollment":13},{"nctId":"NCT05364866","phase":"","title":"CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-05-01","conditions":"Cardiovascular Diseases","enrollment":200},{"nctId":"NCT03531502","phase":"NA","title":"Initial Management of Patients Receiving a Single Shock (IMPRESS)","status":"TERMINATED","sponsor":"Saint Luke's Health System","startDate":"2018-04-09","conditions":"Ventricular Tachycardia","enrollment":30},{"nctId":"NCT04208997","phase":"PHASE3","title":"Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2019-12-19","conditions":"Tachycardia, Ventricular, Catheter Ablation","enrollment":5},{"nctId":"NCT03437356","phase":"NA","title":"Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drugs in Persistent Atrial Fibrillation","status":"COMPLETED","sponsor":"AZ Sint-Jan AV","startDate":"2018-02-26","conditions":"Atrial Fibrillation","enrollment":210},{"nctId":"NCT00911508","phase":"NA","title":"Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-11-13","conditions":"Atrial Fibrillation, Arrhythmia","enrollment":2204},{"nctId":"NCT03228823","phase":"PHASE4","title":"Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)","status":"UNKNOWN","sponsor":"Hunter Holmes Mcguire Veteran Affairs Medical Center","startDate":"2018-08-01","conditions":"Ventricular Premature Beats, Contractions, or Systoles, Cardiomyopathies","enrollment":5},{"nctId":"NCT03734562","phase":"NA","title":"Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia","status":"COMPLETED","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2010-07","conditions":"Monomorphic Ventricular Tachycardia","enrollment":180},{"nctId":"NCT01477983","phase":"PHASE4","title":"Kansai Plus Atrial Fibrillation Trial","status":"COMPLETED","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2011-11","conditions":"Atrial Fibrillation","enrollment":2113},{"nctId":"NCT02294955","phase":"NA","title":"Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)","status":"UNKNOWN","sponsor":"Uppsala University Hospital","startDate":"2008-05","conditions":"Atrial Fibrillation, Quality of Life","enrollment":152},{"nctId":"NCT02303639","phase":"PHASE4","title":"Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias","status":"UNKNOWN","sponsor":"Central Finland Hospital District","startDate":"2015-04","conditions":"Myocardial Infarction, Ventricular Tachyarrhythmia","enrollment":120},{"nctId":"NCT02475642","phase":"PHASE4","title":"Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation","status":"UNKNOWN","sponsor":"VZW Cardiovascular Research Center Aalst","startDate":"2014-03","conditions":"Atrial Fibrillation","enrollment":152},{"nctId":"NCT02114528","phase":"PHASE4","title":"Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2014-10","conditions":"Ventricular Tachycardia, Ventricular Arrhythmia","enrollment":40},{"nctId":"NCT01798277","phase":"PHASE3","title":"Trial Comparing Ablation With Medical Therapy in Patients With Ventricular Tachycardia","status":"WITHDRAWN","sponsor":"Newmarket Electrophysiology Research Group Inc","startDate":"2013-04","conditions":"Ventricular Tachycardia, Coronary Artery Disease","enrollment":""},{"nctId":"NCT00589303","phase":"PHASE3","title":"AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2007-12","conditions":"Atrial Fibrillation, Heart Failure","enrollment":27},{"nctId":"NCT00578617","phase":"NA","title":"Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-09","conditions":"Atrial Fibrillation, Arrhythmia","enrollment":60},{"nctId":"NCT01709682","phase":"PHASE2","title":"A Comparison of the Drug Therapy Versus Re-Ablation","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2007-11","conditions":"Paroxysmal Atrial Fibrillation, Failed First Radiofrequency Ablation Procedure","enrollment":154},{"nctId":"NCT01411371","phase":"NA","title":"Catheter Ablation Versus Medical Treatment of AF in Heart Failure","status":"UNKNOWN","sponsor":"Barts & The London NHS Trust","startDate":"2005-03","conditions":"Atrial Fibrillation, Heart Failure","enrollment":60},{"nctId":"NCT00007605","phase":"PHASE3","title":"Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"1998-04","conditions":"Atrial Fibrillation, Cerebrovascular Accident, Death, Sudden","enrollment":706},{"nctId":"NCT00392106","phase":"PHASE3","title":"High Intensity Focused Ultrasound (HIFU) Ablation System Study","status":"SUSPENDED","sponsor":"ProRhythm, Inc.","startDate":"2006-04","conditions":"Atrial Fibrillation","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13956,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Sotalol or Amiodarone","genericName":"Sotalol or Amiodarone","companyName":"Universitaire Ziekenhuizen KU Leuven","companyId":"universitaire-ziekenhuizen-ku-leuven","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sotalol and Amiodarone are antiarrhythmic drugs that block potassium channels and slow electrical conduction in the heart to restore and maintain normal heart rhythm. Used for Atrial fibrillation for rhythm control and stroke prevention, Ventricular arrhythmias including ventricular tachycardia, Supraventricular tachycardia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}